Myeloid/lymphoid neoplasms with eosinophilia and PDGFRB rearrangements typically present as chronic myeloid neoplasms and are classified as a distinct entity in the World Health Organization (WHO) classification. The gene discussed is PDGFRB; the disease is Increased total eosinophil count.